Bionano Genomics, Inc. (BNGO) stock
BNGONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 12/3083% below fair value
$0.98+0.02 (+2.50%)
Close on Nov 18, 2026Market cap $11.49MP/E –Yield –
Bionano Genomics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Bionano Genomics's price to book ratio was 0.4× on Nov 11, 2026, against 0.4× a year earlier. Over the last 5 years it ranged from 0.1× to 2.5×, with a median of 0.5×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.4× | +0.1 |
| 2025 | Dec 31, 2025 | 0.3× | −0.2 |
| 2024 | Dec 31, 2024 | 0.5× | −0.0 |
| 2023 | Dec 29, 2023 | 0.6× | −1.0 |
| 2022 | Dec 30, 2022 | 1.5× | −0.9 |
| 2021 | Dec 31, 2021 | 2.5× | −28.7 |
| 2020 | Dec 31, 2020 | 31.1× | +26.3 |
| 2019 | Jul 31, 2019 | 4.8× | +1.4 |
| 2018 | Dec 31, 2018 | 3.5× | – |
See a number that looks wrong?